Cookies on this site

Christophe Ravaud

Postdoctoral Research Scientist

I studied Genetics and Development at University Nice Cote d’Azur, in France where I completed my PhD from 2013 to 2017.

My PhD research was about the side effects of the HAART therapy on the human adipose stem cells, focusing on their self-renewal and differentiation into white and brown adipocytes. After completion my PhD, I moved to Oxford and started to work as a Postdoctoral Research Scientist in Prof. Paul Riley’s group at DPAG and Oxstem, an Oxford spin-out which plans to develop small molecule drugs that can activate repair mechanisms that already exist within the body.

Since May 2020, I have joined an MRC programme in Prof. Paul Riley’s group to study immunomodulation following cardiac injury. More specifically, I am investigating cardiac lymphangiogenesis, which occurs post-myocardial infarction in order to optimise the local injury environment for tissue repair after a heart attack.

Recent publications

Phenotypic screening identifies kenpaullone as a prolymphangiogenic compound to improve heart repair following myocardial infarction

Journal article

Ravaud C. et al, (2026), Proceedings of the National Academy of Sciences of the United States of America, 123

Lymphatic clearance of immune cells in cardiovascular disease

Journal article

Ravaud C. et al, (2021), Cells, 10

More publications